VYOME HOLDINGS, INC. (HIND) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
27/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseHIND / S&P 0.00% / 15.20% |
LoseHIND / S&P -97.99% / 15.00% |
LoseHIND / S&P -100.03% / 50.40% |
| 2026-Q10/3 |
LoseHIND / S&P -37.50% / -4.33% |
LoseHIND / S&P -81.26% / 11.30% |
LoseHIND / S&P -84.99% / 27.70% |
| 2025-Q40/3 |
LoseHIND / S&P -33.59% / 2.65% |
LoseHIND / S&P -69.70% / 9.00% |
LoseHIND / S&P -66.76% / 13.40% |
| 2025-Q31/3 |
LoseHIND / S&P -46.93% / 8.12% |
LoseHIND / S&P -48.74% / 4.61% |
WinHIND / S&P 196.12% / 13.45% |
| 2025-Q21/3 |
LoseHIND / S&P -72.96% / 10.94% |
LoseHIND / S&P -19.81% / 4.83% |
WinHIND / S&P 2956.23% / 10.63% |
| 2025-Q11/3 |
LoseHIND / S&P -91.91% / -4.27% |
LoseHIND / S&P -13.92% / 4.98% |
WinHIND / S&P 4884.00% / 10.57% |
| 2024-Q40/3 |
LoseHIND / S&P -21.06% / 2.41% |
LoseHIND / S&P -7.74% / 5.25% |
LoseHIND / S&P -17406.20% / 6.15% |
| 2024-Q31/3 |
LoseHIND / S&P -49.26% / 5.89% |
LoseHIND / S&P -16.55% / 5.89% |
WinHIND / S&P 1503.25% / 6.11% |
| 2024-Q22/3 |
WinHIND / S&P 4.35% / 4.28% |
LoseHIND / S&P -23.00% / 5.38% |
WinHIND / S&P 204.48% / 5.12% |
| 2024-Q11/3 |
LoseHIND / S&P -26.40% / 10.56% |
LoseHIND / S&P -24.82% / 5.71% |
WinHIND / S&P 21.07% / 5.59% |
| 2023-Q40/3 |
LoseHIND / S&P -26.04% / 11.69% |
LoseHIND / S&P -22.79% / 6.81% |
LoseHIND / S&P -125.00% / 7.78% |
| 2023-Q30/3 |
LoseHIND / S&P -77.16% / -3.27% |
LoseHIND / S&P -13.01% / 7.52% |
LoseHIND / S&P -54.19% / -5.03% |
| 2023-Q20/3 |
LoseHIND / S&P -42.41% / 8.74% |
LoseHIND / S&P -14.23% / 9.50% |
LoseHIND / S&P -65.19% / -8.57% |
| 2023-Q10/3 |
LoseHIND / S&P -61.87% / 7.50% |
LoseHIND / S&P -13.51% / 10.77% |
LoseHIND / S&P -45.74% / -15.69% |
| 2022-Q40/3 |
LoseHIND / S&P -55.07% / 7.56% |
LoseHIND / S&P -17.35% / 11.88% |
LoseHIND / S&P -23.53% / -17.99% |
| 2022-Q31/3 |
LoseHIND / S&P -48.01% / -4.88% |
LoseHIND / S&P -17.51% / 13.47% |
WinHIND / S&P 3884.77% / -1.41% |
| 2022-Q21/3 |
LoseHIND / S&P -51.10% / -16.10% |
LoseHIND / S&P -10.16% / 13.71% |
WinHIND / S&P 3221.79% / 11.04% |
| 2022-Q11/3 |
LoseHIND / S&P -28.05% / -4.60% |
LoseHIND / S&P 9.27% / 15.97% |
WinHIND / S&P 2764.73% / 42.23% |
| 2021-Q41/3 |
LoseHIND / S&P -43.06% / 11.03% |
WinHIND / S&P 46.38% / 15.00% |
LoseHIND / S&P HIND unavailable / 96.40% |
| 2021-Q31/3 |
LoseHIND / S&P -42.40% / 0.58% |
WinHIND / S&P 98.88% / 10.77% |
LoseHIND / S&P HIND unavailable / 69.42% |
| 2021-Q21/3 |
LoseHIND / S&P -40.90% / 8.55% |
WinHIND / S&P 276.43% / 6.58% |
LoseHIND / S&P HIND unavailable / 51.81% |
| 2021-Q12/3 |
WinHIND / S&P 88.00% / 6.17% |
WinHIND / S&P 413.21% / -1.06% |
LoseHIND / S&P HIND unavailable / 7.39% |
| 2020-Q42/3 |
WinHIND / S&P 64.84% / 12.15% |
WinHIND / S&P 183.18% / -3.72% |
LoseHIND / S&P HIND unavailable / -33.42% |
| 2020-Q32/3 |
WinHIND / S&P 28.90% / 8.93% |
WinHIND / S&P 51.68% / -2.04% |
LoseHIND / S&P HIND unavailable / -27.10% |
| 2020-Q20/3 |
LoseHIND / S&P -1.94% / 20.54% |
LoseHIND / S&P -49.86% / -0.46% |
LoseHIND / S&P HIND unavailable / -27.11% |
| 2020-Q10/3 |
LoseHIND / S&P -62.11% / -19.60% |
LoseHIND / S&P -76.01% / 3.47% |
LoseHIND / S&P HIND unavailable / -14.75% |
| 2019-Q40/3 |
LoseHIND / S&P -2.06% / 9.07% |
LoseHIND / S&P -63.95% / 5.36% |
LoseHIND / S&P HIND unavailable / 2.99% |
| 2019-Q30/3 |
LoseHIND / S&P -72.25% / 1.70% |
LoseHIND / S&P -57.89% / 5.02% |
LoseHIND / S&P HIND unavailable / 0.21% |
| 2019-Q20/3 |
LoseHIND / S&P -51.46% / 4.30% |
LoseHIND / S&P -31.95% / 6.64% |
LoseHIND / S&P HIND unavailable / 8.65% |
| 2019-Q10/3 |
LoseHIND / S&P -30.43% / 13.65% |
LoseHIND / S&P -2.64% / 8.12% |
LoseHIND / S&P HIND unavailable / 14.29% |
| 2018-Q40/3 |
LoseHIND / S&P -23.33% / -13.52% |
LoseHIND / S&P -8.46% / 9.05% |
LoseHIND / S&P HIND unavailable / 18.23% |
| 2018-Q32/3 |
WinHIND / S&P 25.58% / 7.71% |
WinHIND / S&P 53.19% / 10.21% |
LoseHIND / S&P HIND unavailable / 19.06% |
| 2018-Q21/3 |
LoseHIND / S&P -37.32% / 3.43% |
WinHIND / S&P 110.80% / 9.03% |
LoseHIND / S&P HIND unavailable / 14.46% |
| 2018-Q11/3 |
LoseHIND / S&P -48.11% / -0.76% |
WinHIND / S&P 155.96% / 7.68% |
LoseHIND / S&P HIND unavailable / 12.46% |
| 2017-Q41/3 |
LoseHIND / S&P -30.64% / 6.64% |
WinHIND / S&P 193.02% / 7.03% |
LoseHIND / S&P HIND unavailable / 13.82% |
| 2017-Q31/3 |
LoseHIND / S&P -3.83% / 4.48% |
WinHIND / S&P 94.84% / 5.68% |
LoseHIND / S&P HIND unavailable / 17.57% |
| 2017-Q21/3 |
LoseHIND / S&P -7.30% / 3.09% |
WinHIND / S&P 27.62% / 4.83% |
LoseHIND / S&P HIND unavailable / 17.74% |
| 2017-Q11/3 |
WinHIND / S&P 20.79% / 6.07% |
LoseHIND / S&P HIND unavailable / 3.67% |
LoseHIND / S&P HIND unavailable / 13.32% |
| 2016-Q40/3 |
LoseHIND / S&P HIND unavailable / 3.82% |
LoseHIND / S&P HIND unavailable / 2.09% |
LoseHIND / S&P HIND unavailable / 7.05% |
| 2016-Q30/3 |
LoseHIND / S&P HIND unavailable / 3.85% |
LoseHIND / S&P HIND unavailable / 0.20% |
LoseHIND / S&P HIND unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | HIND total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -75.98% | 20.78% |
| Annualized return | -75.98% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | HIND total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -92.56% | 12.86% |
10Y · 2016-10-06 to 2026-08-27
| Metric | HIND total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -83.29% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |